A multikinase inhibitor used in the second-line setting for hepatocellular carcinoma offers limited increases in quality-adjusted life years. READ MORE
Curative therapies are more likely to be prescribed when liver cancer patients are evaluated by a multidisciplinary team of specialists.
A simplified prognostic score may increase the accuracy of survival prediction after hepatectomy for intrahepatic cholangiocarcinoma.
A single nucleotide polymorphism in the tolloid-like 1 gene is associated with the development of hepatocellular carcinoma after eradication of HCV infection.